NEW YORK, NY / ACCESS Newswire / October 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ:MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin […]
(NYSE:EHC), NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public. SO WHAT: If
EHC Investor News: If You Have Suffered Losses in Encompass Health Corporation (NYSE: EHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on
(NASDAQ:SLP), NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public. SO WHAT: If
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on
(NASDAQ:SVRA), NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”), of the important November 7, 2025 lead plaintiff deadline. SO WHAT: If you
ROSEN, A LONGSTANDING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action- SVRA GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024
King of Prussia, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biotechnology company Alector announced today that the drug, latozinemab, failed to meet the criteria for safety and efficacy in a Phase 3 clinical trial. The study investigated the drug as an intervention for cases of FTD caused by a variant of the gene GRN. Three
Alector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic Treatment did not slow progression of FTD as measured by the clinical co-primary endpoint GlobeNewswire October 21, 2025 King of Prussia, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) — Biotechnology company Alector announced today that the drug, latozinemab, failed to meet the criteria
(TSX:MTL), OKOTOKS, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) — (TSX: MTL) Mullen Group Ltd. (“Mullen Group” and/or the “Corporation“) announced today its intention to redeem in full on December 1, 2025 (the “Redemption Date“) all of its outstanding 5.75% convertible unsecured subordinated debentures due November 30, 2026 (“Debentures“) in accordance with the provisions of the